The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...
Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside Cantor initiated coverage on Aquestive Therapeutics, Inc .
Cantor projects Aquestive shares could rise over 200% in 2025 with Anaphylm approval. Anaphylm is a portable, easy-to-use sublingual epinephrine for Type 1 allergic reactions. The company also ...
A Bay Ridge boy’s life was saved by an EpiPen after going into anaphylactic shock 6 years ago. John Zaremba, 13, says it's not easy living with an allergy. "I have to really think about ...
A teenager claims she was denied her life-saving EpiPen by school staff while she was suffering an allergic reaction. Maya Inez Detari-Hajnal says she was told she was "overreacting" and denied her ...
She told me that when her son Michael was 11 months old, she discovered he had a peanut allergy, requiring an EpiPen. Initially, it only cost her a co-pay of about $20, but then prices skyrocketed.